Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nail disorders from epothilone].

José Pardo1, Pedro Mercader, José L Sánchez

  • 1Servicio de Dermatología, Consorcio Hospital General Universitario, Valencia, Spain. joparsan@hotmail.com

Actas Dermo-Sifiliograficas
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.

Dermatology and therapy·2026
Same author

Genome characterization of the <i>Microbacterium foliorum</i> bacteriophage CookieDog (cluster GA) isolated in Florida, USA.

Microbiology resource announcements·2026
Same author

Long-Term Efficacy and Potential Predictors of Tralokinumab Dose Optimization in Elderly Patients: A Multicentre Study.

Dermatology and therapy·2025
Same author

Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large Well-Described Cohort.

AJPM focus·2023
Same author

Reasons for antiretroviral switching in Colombia: A retrospective cohort study.

International journal of STD & AIDS·2023
Same author

Analytical and computational properties of the variable symmetric division deg index.

Mathematical biosciences and engineering : MBE·2022

Epothilone, a microtubule-disrupting chemotherapy for non-microcytic lung carcinoma, caused severe nail side effects like pain, structural damage, and discoloration in two patients. These adverse effects resemble those seen with taxanes.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Non-microcytic lung carcinoma treatment involves chemotherapy.
  • Epothilone is a novel chemotherapeutic agent targeting microtubule dynamics.

Observation:

  • Two patients with non-microcytic lung carcinoma received epothilone treatment.
  • Patient 1 experienced painful, hemorrhagic fingernails progressing to onycholysis and paronychia, requiring antibiotics and nail removal.
  • Patient 2 developed asymptomatic toenail dyschromia.

Findings:

  • Epothilone treatment can lead to significant nail-related adverse events.
  • Observed nail toxicities include pain, structural damage, onycholysis, paronychia, and dyschromia.
  • The adverse effect profile of epothilone on nails is similar to that of taxanes.

Related Experiment Videos

Implications:

  • Nail toxicity is a notable side effect of epothilone chemotherapy.
  • Awareness of these potential adverse effects is crucial for clinicians managing patients on epothilone.
  • Further research may explore strategies to mitigate epothilone-induced nail toxicities.